M, male; F, female ;AA, aplastic anemia; ALL, acute lymphoblastic leukemia; AML, acute myeloblastic leukemia; FA, Fanconi anemia; HLH, hemophagocytic lymphohistiocytosis; MDS, myelodysplastic syndrome; MPAL, mixed-phenotype acute leukemia; MPS, mucopolysaccharidosis; MS, myeloid sarcoma; HLA, human leukocyte antigen; Bu, busulfan; Cy, cyclophosphamide; Flu, fludarabine; ATG, anti-thymocyte globulin; ALG, anti-lymphocyte globulin; VP-16, etoposide; TBI, total body irradiation; GVHD, graft-versus-host disease; CsA, cyclosporin A; MMF, mycophenolate mofetil; MTX, methotrexate; FK506, tacrolimus; PTCy, post-transplant cyclophosphamide; MNC, mononuclear cells.
Table 2 Clinical features of pediatric patients with TA-TMA